NIH promotes use of lower cost drugs for hypertensionBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7439.539 (Published 04 March 2004) Cite this as: BMJ 2004;328:539
- David Spurgeon
The US National Institutes of Health is planning to use some 600 prominent doctors in the United States, Canada, and Puerto Rico to promote the use of lower cost drugs to treat hypertension.
Currently, the cost of antihypertensive drugs in the United States amounts to about $15bn (£8bn; €12bn), accounting for 10% of the country's total spending on drugs. The institutes' $3.7m initiative is the first time it has tried to promote a change in …
Log in using your username and password
Log in through your institution
Sign up for a free trial